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ABSTRACT
Background. There is a variation in dialysis withdrawal rates,
but reasons for this variation across European countries are
largely unknown. We therefore surveyed nephrologists’ per-
ceptions of factors concerning dialysis withdrawal and pallia-
tive care and explored relationships between these perceptions
and reports of whether withdrawal actually occurred in prac-
tice.
Methods. We developed a 33-item electronic survey, dissemi-
nated via an email blast to all European Renal Association–
European Dialysis and Transplant Association (ERA-EDTA)
members. In our data analyses, we distinguished those respon-
dents who reported occurrence from those reporting no dialy-
sis withdrawal in their unit. With multilevel logistic regression,
we investigated the association between respondents’ charac-
teristics and perceptions and whether they reported occur-
rence of dialysis withdrawal or not.
Results. Five hundred and twenty-eight nephrologists from
45 countries completed the questionnaire; 42% reported
occurrence of withdrawal in their unit in the past year, and 56%
perceived that stopping life-prolonging treatment in terminally
ill patients was allowed. Few respondents reported presence in
their unit of protocols on withdrawal decision making (7%) or
palliative care (10%) or the common involvement of a geriatri-
cian in withdrawal decisions (10%). The majority stated that pal-
liative care had not been part of their core curriculum (74%) and
that they had not recently attended continuous medical
education sessions on this topic (73%). Respondents from
Eastern and Southern Europe had a 42 and 40% lower probabil-
ity, respectively, of reporting withdrawal compared with those
from North European countries. Working in a public centre
[odds ratio (OR), 2.41; 95% conﬁdence interval (CI), 1.36–4.25]
and respondents’ perception that stopping life-prolonging treat-
ment in terminally ill patients was allowed (OR, 1.96; 95% CI,
1.23–3.12), that withdrawal decisions were commonly shared
between doctor and patient (OR, 1.97; 95% CI, 1.26–3.08) and
that palliative care was reimbursed (OR, 1.81; 95% CI, 1.16–
2.83) increased the odds of reporting occurrence of withdrawal.
Conclusion. Reports of dialysis withdrawal occurrence varied
between European countries. Occurrence reports were more
likely if respondents worked in a public centre, if stopping life-
prolonging treatments was perceived as allowed, if withdrawal
decisions were considered shared between doctors and patients
and if reimbursement of palliative care was believed to be in
place. There is room for improvement regarding protocols on
withdrawal and palliative care processes and regarding nephrol-
ogists’ training and education on end-of-life care.
Keywords: dialysis, withdrawal, end of life care, palliative
care, conservative care, chronic kidney disease
INTRODUCTION
There is an ongoing debate and increasing room for doubt
about the beneﬁts of starting or continuing dialysis in many
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groups of patients. For the frail elderly, the most rapidly
growing subgroup of patients starting renal replacement
therapy (RRT), there is often an accelerated decrease in the
quality of life and independence after initiation of dialysis [1].
One in ﬁve patients on dialysis are depressed, and one-third
have different degrees of cognitive impairment [2]. Further-
more, it remains unclear whether RRT prolongs life in this
elderly patient population [2]. Results from a Canadian survey
showed that nearly two out of three patients declared they re-
gretted having started RRT [3]. Over the last decade, the inci-
dence of withdrawals has been increasing [4, 5], as has the
interest for issues related to withdrawal decisions.
Reports on incidence of dialysis withdrawal show consider-
able variation between centres [6]. This variation may partly
stem from differences in patient case mix [5, 7], deﬁnitions of
withdrawal or palliative care [8–10], attitudes of clinicians and
patients to end-of-life care planning and choosing not to have
dialysis (conservative care) [6, 11, 12], training and education of
nephrologists and patients on end-of-life care [13] or differences
in how palliative care is organized [9, 10]. Furthermore, from an
international perspective, withdrawal of dialysis and end-of-life
practices may differ between high and low income countries.
Sociocultural and legal–ethical factors also play a role in the
management of patients after withdrawal from RRT [10].
The reasons for variation in withdrawal rates across Europe
are currently poorly understood. The European Renal Best
Practice (ERBP) group has therefore undertaken a survey in an
international sample of nephrologists on their perceptions of
factors concerning dialysis withdrawal and to explore the rela-
tionship between these perceptions and reports of whether
withdrawal occurred in their practice.
METHODS
We developed a 33-item English electronic survey in Survey-
Monkey® (Supplementary Data 1) to explore nephrologists’
perceptions on withdrawal of haemodialysis and palliative care
after withdrawal. Within the survey, withdrawal was deﬁned as
‘the deliberate cessation of dialysis treatment even though dia-
lysis is technically still possible’ [8] and palliative care as ‘the
care provided to patients with end-stage renal disease after dia-
lysis has been withdrawn’. It concerns the ‘set of treatments
that aim to maximize the comfort and quality of life of these
patients during the last stages of their life, even if this would
hasten death’.
Survey items were derived by two authors (M.W.M.v.d.L.
and S.N.v.d.V.) from guidelines and review articles on palliative
care and dialysis withdrawal [14–18], and referred to the per-
ception of the respondent on legal–ethical issues around
end-of-life care, the decision-making process and patient views
around dialysis withdrawal, and on the organization and reim-
bursement of palliative care, palliative care training and educa-
tion. This preliminary list was then reviewed and
complemented by the other authors to the ﬁnal version. The
ﬁnal questionnaire was piloted by a panel of six nephrologists
and geriatricians for clarity and completeness in the Survey-
Monkey format.
We also asked respondents to estimate the percentage of
haemodialysis patients under their direct care who had actual-
ly withdrawn from treatment (<1, 1–5, 6–10 and >10%) in the
last 12 months.
Data collection and analysis
We disseminated the questionnaire via an email blast to all
members of the European Renal Association–European Dialysis
and Transplant Association (ERA-EDTA) and sent reminders
after 3 and 6 weeks. We collected data with SurveyMonkey® in
October and November 2013.
Lambie et al. [6] used a 1% cut-off to distinguish clini-
cians who have an open attitude towards withdrawal from
those who are more aversive. Accordingly, we classiﬁed
those who estimated the percentage of withdrawals in
haemodialysis patients under their direct care to be <1% in
the last 12 months as ‘reporting no withdrawals’; all others
were classiﬁed as ‘reporting occurrence of withdrawals’.
Using descriptive statistics as appropriate, we summarized
the data separately for these two groups. To investigate the
association between respondents’ characteristics and per-
ceptions (independent variables), and whether they reported
occurrence of withdrawal (outcome of interest), we con-
structed for each independent variable an unadjusted multi-
level logistic regression model as well as a model in which
we adjusted for every other independent variable that met
the criteria for confounding [19]. Clustering of responses
within countries was addressed by adding country-level
random intercepts to all models. In the primary analyses, we
used a Type I error risk (α) of 5% to assess statistical signiﬁ-
cance, while in a sensitivity analysis, we applied a Bonferro-
ni correction to account for multiple testing.
Since we expected the legal–ethical context of countries to
inﬂuence respondents’ perceptions of withdrawal, we addition-
ally summarized responses regarding laws and regulations at
the country level, including only countries with at least 10 re-
spondents. For these countries, we performed a univariate
linear regression analysis to explore the association between
geographical region and the percentage of respondents report-
ing withdrawal occurrence. Countries were assigned to a Euro-
pean region (north, south, east and west) following the
classiﬁcation of countries from the 2012 Revision of the World
Population Prospects by the United Nations [20]. For this
article, Europe was deﬁned as the capture area of ERA-EDTA.
All analyses were performed in SPSS version 22.
RESULTS
In total, 528 nephrologists from 45 countries completed the
questionnaire; we were not able to calculate a response rate
due to the fact that survey distribution was done by blast
email. The majority of respondents were male (64%), had over
10 years of clinical experience (77%), worked in a public
centre (76%) and had >50 haemodialysis patients under their
direct care (57%). Of all respondents, 220 (42%) reported oc-
currence of withdrawal in the past 12 months. Table 1 presents
respondents’ characteristics and perceptions, distinguishing
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those reporting occurrence of withdrawal from those who re-
ported no withdrawals.
Laws and regulations
Overall, 295 (56%) respondents perceived that stopping
life-prolonging treatment in terminally ill patients was formal-
ly or informally allowed in their country, and 172 (33%) re-
ported to be aware of an explicit law or ofﬁcial regulation
regarding the right for palliative care.
Table 2 shows that there was considerable variation between
countries in the percentage of respondents reporting withdrawal
occurrence. Countries with a high percentage of respondents
reporting occurrence of withdrawal had a higher percentage of
reporting that stopping life-prolonging treatment was allowed
(Figure 1) and that there was a national law or regulation avail-
able (Figure 2A). At the regional level, almost half of respondents
from countries in Northern and Western Europe reported the
availability of a law or regulation on palliative care, while this was
25 and 24% in Southern and Eastern Europe, respectively
(Figure 2B).
Our univariate country-level linear regression analysis showed
that—compared with countries in Northern Europe—the prob-
ability of reporting occurrence of withdrawal in Southern and
Eastern Europe was 42 and 40% lower, respectively (P < 0.01), but
was similar in countries inWestern Europe (4% lower; P = 0.71).
Dialysis withdrawal
Table 1 displays that the majority of respondents (64%)
perceived the withdrawal decision to be commonly shared
between doctor and patient/family, but 43% would withdraw if
the family did not support a patient’s decision to withdraw.
Table 1. Respondents’ characteristics and perceptions, presented separately for those reporting occurrence of withdrawal versus reporting no withdrawals,
taking into account eventual clustering of answers on country levela
Occurrence of withdrawals (n = 220) No withdrawals (n = 308)
Characteristics
Male gender 149 (68) 187 (61)
Years of clinical experience
<5 21 (10) 26 (8)
5–10 29 (13) 45 (15)
10–20 76 (35) 86 (28)
>20 94(43) 151 (49)
Number of HD patients under respondent’s direct care
<25 54 (25) 74 (24)
25–50 42 (19) 56 (18)
>50 124 (56) 178 (58)
Working in a public centre 181 (82) 218 (71)
Perceptions
Laws and regulations
Stopping life-prolonging treatment is allowedb 159 (72) 136 (44)
Regulation of the right for palliative care
Explicit law 71 (32) 52 (17)
No explicit law, but ofﬁcial regulation 26 (12) 23 (8)
No ofﬁcial regulation, but permissive attitude 91 (41) 154 (50)
None of the above 32 (15) 79 (26)
Withdrawal decision-making process
Presence of local protocol on withdrawal decision making 23 (10) 14 (5)
Geriatrician consulted in ≥25% of withdrawal decisions 31 (15) 20 (6)
Who makes the decision
Doctor alone 36 (16) 44 (14)
Patient/family alone 15 (7) 86 (28)
Shared decision between doctor and patient/family 169 (77) 170 (55)
Would withdraw even if patient’s decision is not supported by family 102 (46) 124 (40)
Organization of palliative care after withdrawal
Presence of local protocol on organization of palliative care 34 (15) 21 (7)
Palliative care organizations
Government or private for-proﬁt organizations 99 (45) 128 (42)
Private not-for-proﬁt organizations and volunteers 86 (39) 108 (35)
Not organized or do not know 35 (16) 72 (23)
Palliative care is fully or partly reimbursed 153 (70) 152 (49)
Palliative care training and education
Presence of dedicated specialist training on palliative care 129 (59) 123 (40)
Palliative care as explicit topic within nephrology curriculum 43 (20) 24 (8)
Attending CME sessions on palliative care in last 3 years 79 (36) 62 (20)
Values are numbers (%). CME, continuous medical education; HD, haemodialysis.
aThose who estimated the percentage of withdrawals in haemodialysis patients under their direct care to be <1% in the last 12 months were classiﬁed as ‘reporting no withdrawals’, and
all others as ‘reporting occurrence of withdrawals’.
bRefers to perception that stopping life-prolonging treatment in terminally ill patients is formally or informally allowed.
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Overall, local protocols (7%) and consultation of a geriatrician
(10%) were rarely reported as being in place.
With regard to perceived patient views on dialysis withdrawal,
the majority of respondents believed that the imbalance between
treatment burden and expected survival beneﬁt was the main
reason for patients to withdraw (79%) or because they wanted
to relieve the burden for their family (23%). The most
frequently reported perceived reasons by the respondents on
why patients who were considering to withdraw would still
continue their treatment were fearing a lack of adequate
further medical support (35%), lack of social support at home
(27%) and lack of suitable palliative care facilities (27%). Fur-
thermore, respondents indicated that they expected that more
patients would opt for withdrawal if better logistical services
around withdrawal and palliative care were available (43%), if
nephrologists had more knowledge on palliative care (33%) or
if more palliative care specialists would be available (34%).
Palliative care
Palliative care after dialysis withdrawal was most often
reported to be fully or partly reimbursed (58%) and organized
by government or private for-proﬁt organizations (43%);
reports of availability of local protocols around organization of
palliative care were uncommon (9%) (Table 1). Of all survey
participants, 41% (n = 214) indicated that the majority of
patients were sent home after withdrawal, with 31% (n = 66)
of them reporting that most patients were ﬁrst admitted to the
hospital to prepare them for the new situation at home. Others
reported referral destinations for withdrawn patients were
general hospices (16%) and specialist palliative care hospices
(17%).
Table 1 shows that the majority of nephrologists stated that
palliative care was an acknowledged medical specialty in their
country (48%), that it had not been part of their core curric-
ulum (74%) and that they had not recently attended continu-
ous medical education (CME) sessions on palliative care
(73%) because these were not organized or because they
deemed other sessions more relevant.
Table 2. Country-level resultsa for items related to legal–ethical context, ordered by the percentage of respondents reporting withdrawal occurrence
Country Region Number of
respondents
Occurrence of
withdrawal
Stopping life-prolonging
treatment is allowedb
National law or regulation of right for palliative care
Explicit
law
Ofﬁcial
regulation
No regulation, but
permissive attitude
No regulation, no
permissive attitude
Belgium West 19 79 95 53 5 42 0
UK North 46 72 80 17 11 65 7
France West 34 65 65 59 3 29 9
The
Netherlands
West 14 64 100 29 14 57 0
Austria West 13 62 69 39 15 39 8
Sweden North 15 60 93 40 13 40 7
Switzerland West 13 54 100 31 15 54 0
Spain South 48 50 73 38 21 31 10
Germany West 37 49 57 24 22 49 5
Czech
Republic
East 12 33 33 17 17 42 25
Portugal South 14 29 71 43 21 29 7
Romania East 18 28 33 11 0 56 33
Egypt South 15 27 20 0 0 53 47
Russia East 11 27 18 9 18 9 64
Greece South 26 23 8 12 0 39 50
Poland East 17 18 53 24 0 59 18
Italy South 77 13 40 7 3 53 38
Croatia South 11 0 27 0 0 55 45
Values are numbers (%).
aResults displayed for countries with at least 10 respondents.
bRefers to respondents’ perception that life-prolonging treatment in terminally ill patients is formally or informally allowed in their country.
F IGURE 1 : Bubble plot presenting the association between percent-
age of respondents in a country reporting occurrence of withdrawal
(y-axis) and reporting that stopping life-prolonging treatment in ter-
minally ill patients is—formally or informally—allowed (x-axis). Each
bubble represents a country; the bigger the bubble, the more respon-
dents in a country. The R2 value implies that 62% of the variance in
reported occurrence of withdrawal in our data set is explained by
reports on stopping life-prolonging treatment being perceived as
allowed.
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Respondents’ characteristics and perceptions associated
with reports of withdrawal occurrence
Table 3 shows the results of the multilevel analyses of the
association between respondents’ characteristics and percep-
tions and their reports of withdrawal occurrence. The odds of
nephrologists working in public centres to report occurrence
of withdrawal were more than twice as high compared with
those working in a private centre [odds ratio (OR), 2.41; 95%
conﬁdence interval (CI), 1.36–4.25]. Perceiving that stopping
life-prolonging treatment in terminally ill patients was
allowed (OR, 1.96; 95% CI, 1.23–3.12) and that withdrawal
decisions were commonly shared between doctor and patient
(OR, 1.97; 95% CI, 1.26–3.08) almost doubled respondents’
odds of reporting withdrawal occurrence; this was also true
for reports of that palliative care was fully or partly reim-
bursed (OR, 1.81; 95% CI, 1.16–2.83). Furthermore, we found
a statistically signiﬁcant association between reporting with-
drawal occurrence and reporting recent attendance of CME
sessions on palliative care (OR, 1.68; 95% CI, 1.07–2.65) as
well as between reporting occurrence and reporting that pal-
liative care was an explicit topic within the nephrology curric-
ulum (OR, 1.93, 95% CI, 1.02–3.64). However, the latter
association did not reach statistical signiﬁcance in our sensi-
tivity analysis, whereas all other adjusted analyses showed
similar results.
DISCUSSION
Summary of results
The results of this survey indicate that reports of haemodi-
alysis withdrawal occurrence and perceptions of factors related
to withdrawal of patients on RRT vary considerably between
countries and regions in Europe. Few respondents reported
availability of local protocols around withdrawal and palliative
care. Respondents who perceived that stopping life-prolonging
treatments was allowed, that withdrawal decisions were shared
between doctor and patient or that palliative care was reim-
bursed more often reported that withdrawals had occurred in
their practice in the last year. Working in a public centre and
having attended CME sessions on palliative care were also
factors associated with increased reports of withdrawal occur-
rence.
We observed an association between geographical region
and reports of withdrawal occurrence, with a higher percent-
age of respondents reporting withdrawal in Northern Europe,
compared with Southern and Eastern Europe. Much of the lit-
erature on withdrawal and end-of-life care comes from the
USA and the UK, and only a few publications include compar-
isons between countries [16]. This makes it difﬁcult to get an
insight into the impact of cultural and regional differences on
end-of-life management and decision making. The Anglo-
Saxon culture emphasizes patient autonomy and aspects of
cost–utility, but in many other cultures, not doing as much as
possible for a loved one is considered dishonourable. This
would suggest that ethnicity, regional culture, family structure
and spiritual beliefs may inﬂuence the uptake of and attitude
towards end-of-life care [21, 22]. For example, Thomas et al.
[23] reported a lower likelihood of withdrawal and a lower re-
ferral rate to hospice care for ethnic minorities in the USA,
though it was unclear whether this reﬂected differences in
quality of care or practice patterns according to patient prefer-
ences and cultural attitudes.
In addition, cultural beliefs and attitudes can change over
time under the inﬂuence of better understanding of what a
treatment actually can or cannot achieve [24, 25]. In discus-
sions with patients and their relatives, physicians should there-
fore explain that they believe the treatment does not add
qualitative life years and that this fact steers their concern
about continuing it [26]. However, many physicians may feel
uncomfortable talking about withdrawal with patients [27].
F IGURE 2 : National laws and regulations of the right for palliative care; ﬁgures display results for countries with ≥10 respondents. (A) Per-
centage of respondents per country reporting presence of a certain type of regulation. Countries on the x-axis are ordered based on the percent-
age of reports of withdrawal occurrence, ranging from 79% in Belgium to 0% in Croatia. (B) Percentage of respondents per region reporting
presence of a certain type of regulation.
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They might be uncertain of the patient’s prognosis or—as
identiﬁed in our study—there may be a lack of local protocols
and care plans around end-of-life decisions. Importantly, aver-
sion towards and lack of guidance on having end-of-life deci-
sions with patients have been associated with more aggressive
treatment [28, 29]. Recently, some sensitive and speciﬁc prog-
nostic scores have been developed for short-term prognostica-
tion in patients on haemodialysis [30]. Repetitive assessments
of these scores can be a cue to start changing from a ‘procras-
tination’ approach to a more palliative approach of the patient
[31]. Having such a valid estimation of the prognosis of the
patient can potentially reduce the discomfort of the treating
physician to discuss withdrawal of therapy with the patient
and his/her relatives. In addition to these prognostic tools,
evaluating the patient’s comorbidity proﬁle and functional
status (e.g. using the Charlson comorbidity index and
Karnofsky scale, respectively) and asking the surprise question
(Would I be surprised if this patient died within the next
year?) can all be of use in predicting the patient’s prognosis
[32, 33]. Ideally, prognosis and functional outcome discus-
sions should become a normal facet of routine renal practice.
The large majority of nephrologists participating in our
survey had not recently attended any CME sessions on palliative
care, mainly because they perceive that such sessions were not
organized. This is in line with previous research pointing out the
suboptimal preparation of nephrologists for palliative care and
for communication of end-of-life issues with the patient and the
family [34, 35]. Schell et al. [35] reported that less than one out
of three nephrology fellows was trained in the management of
patients with a poor prognosis, whereas the majority agreed that
having these skills would be necessary to improve their approach
of and communication with these patients. Combs et al. [13]
Table 3. Results of the unadjusted and adjusted analyses of the association between respondent characteristics and perceptions, and reporting occurrence
of withdrawal
Unadjusted analysis Adjusted analysis
OR (95% CI) Adjusted fora OR (95% CI)
Respondent characteristics
Male gender 1.45 (0.96–2.19) 1 1.49 (0.93–2.39)
Years of clinical experience
<5 [reference category] 2
5–10 0.62 (0.25–1.57) 0.63 (0.25–1.63)
>10 0.81 (0.36–1.82) 0.86 (0.38–1.98)
0.62 (0.28–1.39) 0.59 (0.26–1.35)
Number of HD patients under respondent’s direct care
<25 [reference category]
25–50 1.19 (0.66–2.15) 1 1.28 (0.65 –2.51)
>50 1.23 (0.76–2.00) 1 1.47 (0.83–2.58)
Working in a public centre 2.42 (1.45–4.03) 2 2.41 (1.36–4.25)
Respondent perceptions
Laws and regulations
Regulation of the right for palliative care
Explicit law 1.50 (0.80–2.82) 3 1.37 (0.71–2.63)
No explicit law, but ofﬁcial regulation 1.25 (0.57–2.74) 3 1.09 (0.49–2.43)
No ofﬁcial regulation, but permissive attitude 0.86 (0.50–1.49) 3 0.76 (0.43–1.33)
None of the above [reference category]
Stopping life-prolonging treatment is allowedb 2.30 (1.50–3.52) 3, 4 1.96 (1.23–3.12)
Withdrawal decision-making process
Presence of local protocol on withdrawal decision making 1.74 (0.82–3.69) 3, 5 1.50 (0.69–3.28)
Geriatrician consulted in ≥25% of withdrawal decisions 2.00 (1.01–3.96) 3, 5 1.70 (0.84–3.43)
Withdrawal decision shared between doctor and patient/family 1.98 (1.29–3.05) 3, 5 1.97 (1.26–3.08)
Would withdraw even if patient’s decision is not supported by family 1.36 (0.92–2.02) 3, 5 1.31 (0.88–1.97)
Organization of palliative care after withdrawal
Presence of local protocol on organization of palliative care 1.30 (0.67–2.52) 3, 5 1.14 (0.57–2.28)
Palliative care organizations 3, 5
Not organized or do not know [reference category]
Government or private for-proﬁt organizations 1.57 (0.91–2.71) 3, 5 1.62 (0.92–2.85)
Private not-for-proﬁt organizations and volunteers 1.69 (0.97–2.98) 3, 5 1.74 (0.97–3.13)
Palliative care is fully or partly reimbursed 1.87 (1.22–2.88) 3, 5 1.81 (1.16–2.83)
Palliative care training and education
Presence of dedicated specialist training on palliative care 1.48 (0.97–2.26) 3, 5 1.49 (0.96–2.32)
Palliative care as explicit topic within nephrology curriculum 1.98 (1.09–3.61) 3, 5 1.93 (1.02–3.64)c
Attending CME sessions on palliative care in last 3 years 1.73 (1.11–2.70) 3 1.68 (1.07–2.65)
CI, conﬁdence interval; CME, continuous medical education; HD, haemodialysis.
aNumbers in this column refer to the following variables: 1, all other respondent characteristics; 2, all other respondent characteristics except ‘Number of HD patients under respondent’s
direct care’; 3, all respondent characteristics; 4, all other respondent perceptions; 5, regulation of the right for palliative care.
bRefers to perception that stopping life-prolonging treatment in terminally ill patients is formally or informally allowed.
cIn our sensitivity analysis, this association did not reach statistical signiﬁcance after applying a Bonferroni correction, with a 97% CI of 0.95–3.89.
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recently reported that the quality and quantity of palliative and
end-of-life care training had not improved in the last decade.
Based on these and our ﬁndings, particularly that education is
related to positive attitudes towards withdrawal, we suggest that
it is important to invest in improving knowledge of nephrolo-
gists regarding available palliative and end-of-life care options.
Skills to discuss and organize end-of-life should therefore be
recognized as an essential component of continuing medical
education for all practicing nephrologists. Educational bodies,
including the European and national nephrology societies,
should make sure that these topics are included in the curric-
ulum for nephrology trainees and provide CME sessions on this
issue.
Whereas education is an essential prerequisite, it is also
evident that end-of-life conversations take time to prepare and
perform properly. This time might not always be available to
busy clinicians. We will therefore also need a switch in think-
ing about healthcare, putting more emphasis on caring rather
than on curing [36]. To this end, there may be several lessons
to be learned from the oncology ﬁeld, where palliative care
after withdrawal from curative treatment is already integrated
in the current practice. Whereas end-of-life discussions are as-
sociated with lower healthcare expenditure in the oncology
setting [37], economic reasons should not be used as the main
argument to support an open atmosphere to discuss with-
drawal of therapy in patients with poor prognosis and quality
of life: the major argument is that it improves satisfaction and
quality of life in the remaining time of the patient and also the
grieving and bereavement process of the relatives [38].
There was an association between working in a public
centre and occurrence of withdrawal. Due to its design, our
survey does not allow to make a causal relation. This associ-
ation can be best further explored by ﬁrst analysing whether
this difference is due to differences in patient mix (observa-
tional registry data). If such a difference in case mix exist, it
should be explored by qualitative research whether this attrib-
utable to physician preference (cherry picking), to patient pre-
ferences or a combination of both.
Strengths and limitations
Country-level factors, such as legal–ethical context, appeared
to be associated with withdrawal occurrence as reported by indi-
vidual nephrologists. Asking for respondents’ perceptions of
legal–ethical aspects, instead of collecting information on
factual legislations in countries, allowed us to capture a better
reﬂection of attitudes towards withdrawal in daily practice.
Access to and provision of dialysis are somewhat unequal
throughout Europe [39, 40], and therefore, attitudes towards
withdrawal as reported in our survey could potentially be inﬂu-
enced by ﬁnancial and logistical issues. However, the prevalence
of withdrawal seems to be highest in countries with the least ﬁ-
nancial restrictions and the highest prevalence of RRT. This ob-
servation is rather in line with the idea that a higher take on
rate, and thus inclusion of more frail patients, results in higher
withdrawal rates. It does not support the notion that withdrawal
is induced by ﬁnancial restrictions, although it cannot be
excluded that in such cases, withholding might occur. Also,
having respondents from 45 countries from the European
continent participating in the study increased the generalizabil-
ity of our ﬁndings to the broader European renal community.
The survey focused on self-reported attitudes, beliefs and
perceptions, which are susceptible to reporting bias. However,
it is unlikely that respondents who feel so much peer pressure
that they do not even report withdrawal in an anonymous
survey would actually perform it in practice. Also, nephrolo-
gists with a strong interest in end-of-life care may have been
more eager to respond, potentially resulting in selection bias.
We did not use actual case vignettes, which would have
allowed to evaluate the impact of patient age, quality of life
and comorbidity on the attitude of the respondent. Lastly, the
occurrence of withdrawal was estimated by respondents and
did not allow us to draw conclusions on actual withdrawal
rates.
CONCLUSION
Reports of occurrence of withdrawal from dialysis are not
uncommon but vary between European countries and regions.
Occurrence was more likely to be reported if stopping life-
sustaining treatments was perceived as being allowed, if with-
drawal decisions were seen as shared decisions between
doctors and patients and if reporting that palliative care was
reimbursed. Also, working in a public centre and having at-
tended CME sessions on palliative care were associated with
increased reports of withdrawal occurrence. There is substan-
tial room for improvement regarding the availability of proto-
cols on the withdrawal and palliative care process and an
urgent need for improving nephrologists’ training and educa-
tion in this ﬁeld.
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